Corcept Therapeutics

NASDAQ: CORT · Real-Time Price · USD
77.54
-0.10 (-0.13%)
At close: May 30, 2025, 3:59 PM
77.75
0.27%
After-hours: May 30, 2025, 05:13 PM EDT

Corcept Therapeutics Revenue

Corcept Therapeutics reported an annual revenue of $675.04M, reflecting a 39.94% growth. For the quarter ending March 31, 2025, Corcept Therapeutics generated $157.21M in revenue.
Revenue (ttm)
$675.04M
Revenue Growth
39.94%
Price / Sales Ratio
7.71
Revenue / Employee
$1.35M
Employees
500
Market Cap
8.22B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.